Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Non Operating Income: 2012-2025

Historic Non Operating Income for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to -$4.1 million.

  • Veracyte's Non Operating Income fell 183.98% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 59.31%. This contributed to the annual value of $9.6 million for FY2024, which is 4.56% up from last year.
  • Per Veracyte's latest filing, its Non Operating Income stood at -$4.1 million for Q3 2025, which was down 162.24% from $6.5 million recorded in Q2 2025.
  • Veracyte's 5-year Non Operating Income high stood at $6.5 million for Q2 2025, and its period low was -$4.1 million during Q3 2025.
  • Moreover, its 3-year median value for Non Operating Income was $2.7 million (2024), whereas its average is $2.3 million.
  • Examining YoY changes over the last 5 years, Veracyte's Non Operating Income showed a top increase of 3,528.57% in 2021 and a maximum decrease of 1,985.71% in 2021.
  • Quarterly analysis of 5 years shows Veracyte's Non Operating Income stood at $1.0 million in 2021, then spiked by 94.78% to $2.0 million in 2022, then surged by 154.42% to $5.0 million in 2023, then crashed by 114.54% to -$732,000 in 2024, then tumbled by 183.98% to -$4.1 million in 2025.
  • Its Non Operating Income was -$4.1 million in Q3 2025, compared to $6.5 million in Q2 2025 and $4.5 million in Q1 2025.